Table 3.
PRIME cohort sample sizes and attrition over time, by disorder and by district
| Depression | AUD | Psychosis | Epilepsy | |||||
|---|---|---|---|---|---|---|---|---|
| Treatment | Comparison | Treatment | Comparison | Patient | Caregivera | Patient | Caregiver | |
| Ethiopia | ||||||||
| Enrolled | 92 | 39 | 51 | – | 300 | 300 | 304 | 304 |
| Attrition at midline | 10 (10.9%) | 0 (0%) | 1 (2.0%) | 53 (17.7%) | 53 (17.7%) | 149 (49.0%) | 149 (49.0%) | |
| Attrition at endline | 13 (14.1%) | 2 (5.1%) | 4 (7.8%) | – | 55 (18.3%) | 55 (18.3%) | 50 (16.4%) | 50 (16.4%) |
| India | ||||||||
| Enrolled | 281 | 158 | 218 | 147 | 22 | 21b | – | – |
| Attrition at midline | 39 (13.9%) | 15 (9.6%) | 27 (12.3%) | 19 (12.9%) | 4 (19.0%) | 0 (0%) | ||
| Attrition at endline | 56 (19.9%) | 19 (12.1%) | 43 (19.6%) | 29 (19.7%) | 4 (19.0%) | 1 (5.0%) | – | – |
| Nepal | ||||||||
| Enrolled | 137 | 72 | 175 | 57 | – | 95 | 42 | – |
| Attrition at midline | 27 (19.7%) | 23 (31.9%) | 40 (22.9%) | 29 (50.9%) | 8 (8.4%) | 2 (4.8%) | ||
| Attrition at endline | 26 (19.0%) | 17 (23.6%) | 33 (18.8%) | 22 (39.3%) | – | 9 (9.5%) | 4 (9.5%) | – |
| South Africa | ||||||||
| Enrolled | 217 | 236 | – | – | 47 | 12 | – | – |
| Attrition at midline | 24 (11.1%) | 27 (11.4%) | 34 (72.3%) | 8 (66.7%) | ||||
| Attrition at endline | 40 (18.4%) | 41 (17.3%) | – | 5 (10.6%) | 2 (11.1%) | – | – | |
| Uganda | ||||||||
| Enrolled | 64 | – | – | – | 51 | 50 | 181 | 171 |
| Attrition at midline | 3 (4.7%) | 4 (7.8%) | 6 (12.0%) | 8 (4.4%) | 8 (4.7%) | |||
| Attrition at endline | 7 (10.9%) | – | – | – | 8 (15.7%) | 12 (24.0%) | 19 (10.5%) | 24 (14.0%) |
aCaregivers recruited together with patient, unless otherwise stated
bEither patient or caregiver recruited